These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22424638)

  • 1. A new approach for anthelmintic discovery for humans.
    Geary TG; Chibale K; Abegaz B; Andrae-Marobela K; Ubalijoro E
    Trends Parasitol; 2012 May; 28(5):176-81. PubMed ID: 22424638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthelmintic drug discovery: into the future.
    Geary TG; Sakanari JA; Caffrey CR
    J Parasitol; 2015 Apr; 101(2):125-33. PubMed ID: 25584662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant products in the treatment and control of filariasis and other helminth infections and assay systems for antifilarial/anthelmintic activity.
    Murthy PK; Joseph SK; Murthy PS
    Planta Med; 2011 Apr; 77(6):647-61. PubMed ID: 20957596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working towards New Drugs against Parasitic Worms in a Public-Development Partnership.
    Preston S; Gasser RB
    Trends Parasitol; 2018 Jan; 34(1):4-6. PubMed ID: 28784352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresolved issues in anthelmintic pharmacology for helminthiases of humans.
    Geary TG; Woo K; McCarthy JS; Mackenzie CD; Horton J; Prichard RK; de Silva NR; Olliaro PL; Lazdins-Helds JK; Engels DA; Bundy DA
    Int J Parasitol; 2010 Jan; 40(1):1-13. PubMed ID: 19932111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products as a screening resource.
    Harvey AL
    Curr Opin Chem Biol; 2007 Oct; 11(5):480-4. PubMed ID: 17884696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?
    Patwardhan B; Mashelkar RA
    Drug Discov Today; 2009 Aug; 14(15-16):804-11. PubMed ID: 19477288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthelmintics: From discovery to resistance II (San Diego, 2016).
    Martin RJ; Wolstenholme AJ; Caffrey CR
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):297-298. PubMed ID: 27814986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confronting the challenges of natural product-based antifungal discovery.
    Roemer T; Xu D; Singh SB; Parish CA; Harris G; Wang H; Davies JE; Bills GF
    Chem Biol; 2011 Feb; 18(2):148-64. PubMed ID: 21338914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the new anthelmintic jonite].
    Cherniaeva AI
    Med Parazitol (Mosk); 1974; 43(3):311-4. PubMed ID: 4459700
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity-based protein profiling for natural product target discovery.
    Krysiak J; Breinbauer R
    Top Curr Chem; 2012; 324():43-84. PubMed ID: 22025071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches.
    Patwardhan B; Vaidya AD
    Indian J Exp Biol; 2010 Mar; 48(3):220-7. PubMed ID: 21046974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products isolation in modern drug discovery programs.
    Gray AI; Igoli JO; Edrada-Ebel R
    Methods Mol Biol; 2012; 864():515-34. PubMed ID: 22367910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our 1st observations on the therapeutic action of mebendazole, new anthelmintic drug, with a broad spectrum of action].
    Amato Neto V; Levi GC; Stefani HN; Konichi SR; Dias JC; Oliveira LR; Campos LL
    Rev Inst Med Trop Sao Paulo; 1973; 15(1):34-7. PubMed ID: 4703904
    [No Abstract]   [Full Text] [Related]  

  • 20. Systems drug discovery: a quantitative, objective approach for safer drug development.
    Bickle M
    Expert Opin Drug Discov; 2012 Sep; 7(9):757-9. PubMed ID: 22827715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.